Cargando…

Lifetime attributable risk of radiation-induced secondary cancer from proton beam therapy compared with that of intensity-modulated X-ray therapy in randomly sampled pediatric cancer patients

To investigate the amount that radiation-induced secondary cancer would be reduced by using proton beam therapy (PBT) in place of intensity-modulated X-ray therapy (IMXT) in pediatric patients, we analyzed lifetime attributable risk (LAR) as an in silico surrogate marker of the secondary cancer afte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamura, Masaya, Sakurai, Hideyuki, Mizumoto, Masashi, Kamizawa, Satoshi, Murayama, Shigeyuki, Yamashita, Haruo, Takao, Seishin, Suzuki, Ryusuke, Shirato, Hiroki, Ito, Yoichi M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440886/ https://www.ncbi.nlm.nih.gov/pubmed/27789564 http://dx.doi.org/10.1093/jrr/rrw088

Ejemplares similares

Particle therapy for prostate cancer: The past, present and future
por: Ishikawa, Hitoshi, et al.
Publicado: (2019)

Proton beam therapy for pediatric malignancies: a retrospective observational multicenter study in Japan
por: Mizumoto, Masashi, et al.
Publicado: (2016)

Long‐term follow‐up after proton beam therapy for pediatric tumors: a Japanese national survey
por: Mizumoto, Masashi, et al.
Publicado: (2017)

Preliminary results of proton radiotherapy for pediatric rhabdomyosarcoma: a multi‐institutional study in Japan
por: Mizumoto, Masashi, et al.
Publicado: (2018)

Clinical experience of craniospinal intensity-modulated spot-scanning proton therapy using large fields for central nervous system medulloblastomas and germ cell tumors in children, adolescents, and young adults
por: Hashimoto, Takayuki, et al.
Publicado: (2019)

Analysis of treatment process time for real‐time‐image gated‐spot‐scanning proton‐beam therapy (RGPT) system
por: Yoshimura, Takaaki, et al.
Publicado: (2019)

Quantitative analysis of treatments using real‐time image gated spot‐scanning with synchrotron‐based proton beam therapy system log data
por: Yoshimura, Takaaki, et al.
Publicado: (2020)

Potential benefits of adaptive intensity‐modulated proton therapy in nasopharyngeal carcinomas
por: Minatogawa, Hideki, et al.
Publicado: (2020)

Synchronization of light flash with the irradiation pulse in proton beam therapy: A case report
por: Saito, Takashi, et al.
Publicado: (2023)

What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy
por: Toramatsu, Chie, et al.
Publicado: (2013)

Proton beam therapy in non-small cell lung cancer: state of the art
por: Harada, Hideyuki, et al.
Publicado: (2017)

A Retrospective Study of Renal Growth Changes after Proton Beam Therapy for Pediatric Malignant Tumor
por: Li, Yinuo, et al.
Publicado: (2023)

Dose escalation study of proton beam therapy with concurrent chemotherapy for stage III non‐small cell lung cancer
por: Harada, Hideyuki, et al.
Publicado: (2016)

Dynamic gating window technique for the reduction of dosimetric error in respiratory‐gated spot‐scanning particle therapy: An initial phantom study using patient tumor trajectory data
por: Miyamoto, Naoki, et al.
Publicado: (2020)

Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas
por: Fuji, Hiroshi, et al.
Publicado: (2013)

Proton beam therapy for bone sarcomas of the skull base and spine: A retrospective nationwide multicenter study in Japan
por: Demizu, Yusuke, et al.
Publicado: (2017)

Prediction of target position from multiple fiducial markers by partial least squares regression in real-time tumor-tracking radiation therapy
por: Ukon, Kanako, et al.
Publicado: (2021)

Proton Beam Therapy for Pediatric Brain Tumor
por: MIZUMOTO, Masashi, et al.
Publicado: (2017)

A simulation study on the dosimetric benefit of real-time motion compensation in spot-scanning proton therapy for prostate
por: Fujii, Yusuke, et al.
Publicado: (2017)

Analysis of acute-phase toxicities of intensity-modulated proton therapy using a model-based approach in pharyngeal cancer patients
por: Yasuda, Koichi, et al.
Publicado: (2020)

Proton beam therapy for renal pelvis and ureter cancer: A report of 5 cases and a literature review
por: Iizumi, Takashi, et al.
Publicado: (2019)

Selection of external beam radiotherapy approaches for precise and accurate cancer treatment
por: Shirato, Hiroki, et al.
Publicado: (2018)

Proton beam therapy for liver metastases from gastric cancer
por: Fukumitsu, Nobuyoshi, et al.
Publicado: (2017)

A motion-compensated image filter for low-dose fluoroscopy in a real-time tumor-tracking radiotherapy system
por: Miyamoto, Naoki, et al.
Publicado: (2015)

High-dose proton beam therapy versus conventional fractionated radiation therapy for newly diagnosed glioblastoma: a propensity score matching analysis
por: Matsuda, Masahide, et al.
Publicado: (2023)

Clinical results of proton beam therapy for advanced neuroblastoma
por: Oshiro, Yoshiko, et al.
Publicado: (2013)

Particle therapy using protons or carbon ions for cancer patients with cardiac implantable electronic devices (CIED): a retrospective multi-institutional study
por: Hashimoto, Takayuki, et al.
Publicado: (2021)

Proton beam therapy for a patient with large rhabdomyosarcoma of the body trunk
por: Takizawa, Daichi, et al.
Publicado: (2015)

A treatment planning study of urethra-sparing intensity-modulated proton therapy for localized prostate cancer
por: Yoshimura, Takaaki, et al.
Publicado: (2021)

A retrospective study of late adverse events in proton beam therapy for prostate cancer
por: Makishima, Hirokazu, et al.
Publicado: (2017)

Long‐term outcomes of proton therapy for prostate cancer in Japan: a multi‐institutional survey of the Japanese Radiation Oncology Study Group
por: Iwata, Hiromitsu, et al.
Publicado: (2018)

Validation of dose distribution for liver tumors treated with real-time-image gated spot-scanning proton therapy by log data based dose reconstruction
por: Yamada, Takahiro, et al.
Publicado: (2021)

A study on predicting cases that would benefit from proton beam therapy in primary liver tumors of less than or equal to 5 cm based on the estimated incidence of hepatic toxicity
por: Uchinami, Yusuke, et al.
Publicado: (2022)

Acute toxicity and patient‐reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer
por: Iizumi, Takashi, et al.
Publicado: (2021)

Long-term outcomes of patients with unresectable benign meningioma treated with proton beam therapy
por: Sato, Hiroshige, et al.
Publicado: (2021)

A Nucleoside Anticancer Drug, 1-(3-C-Ethynyl-β-D-Ribo-Pentofuranosyl)Cytosine, Induces Depth-Dependent Enhancement of Tumor Cell Death in Spread-Out Bragg Peak (SOBP) of Proton Beam
por: Maeda, Kenichiro, et al.
Publicado: (2016)

An Analysis of Vertebral Body Growth after Proton Beam Therapy for Pediatric Cancer
por: Baba, Keiichiro, et al.
Publicado: (2021)

Significance of indocyanine green test in radiotherapy for hepatocellular carcinoma
por: Mizumoto, Masashi, et al.
Publicado: (2019)

Optimal Androgen Deprivation Therapy Combined with Proton Beam Therapy for Prostate Cancer: Results from a Multi-Institutional Study of the Japanese Radiation Oncology Study Group
por: Murakami, Motohiro, et al.
Publicado: (2020)

Proton Beam Therapy for a Patient with a Giant Thymic Carcinoid Tumor and Severe Superior Vena Cava Syndrome
por: Sugawara, Kaori, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u670u5k8qvua49aruu464u7kkl